Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054-MedSci.cn

Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

Eggermont, A; Kicinski, M; Suciu, S

Eggermont, A (通讯作者)，Univ Utrecht, Res Directorate Princess Maxima Ctr, Utrecht, Netherlands.;Eggermont, A (通讯作者)，Univ Utrecht, Canc Med Univ, Med Ctr Utrecht, Utrecht, Netherlands.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022; 10 (1):

科室
- - 订阅+
  - 更多科室
工具
服务